Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of Single Subcutaneous Doses of BCD 057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects

NCT07181694 is registered in ClinicalTrials.gov with Biocad as lead sponsor.

NCT NCT07181694
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07181694 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Comparative, Randomized Clinical Study of the Pharmacokinetics, Safety, and Immunogenicity of Single Subcutaneous Doses of BCD 057 100 mg/mL, BCD-057 50 mg/mL, and Humira 100 mg/mL in Healthy Subjects
Lead sponsor
Biocad
Phase
Phase 1
Overall status
Completed
Start date
March 12, 2025
Completion date
February 12, 2026
Enrollment
444 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adult male